ECR 2014: Future of molecular imaging is now

Kathy Mahdoubi | | Health Imaging | Molecular Imaging

VIENNA—Today marked the opening of the European Congress of Radiology (ECR) 2014 being held March 6-10 at the Austria Center Vienna. This is the 20th annual meeting of the European Society of Radiology (ESR), where an estimated 20,000 participants from 100 countries have come together to discuss the latest news and developments in the worldwide radiological community.

Molecular imaging is a major focus in the program this year, with topics ranging from investigational biomarkers and companion diagnostics; advancements in molecular MRI; applications and challenges concerning hybrid imaging, including PET/MR, PET/CT and SPECT; and techniques in specialties like neuroimaging, oncology and cardiac imaging. 

“People are saying that molecular imaging is the future of radiology, but actually it is already the present of radiology and its future,” said Valentin E. Sinitsyn, MD, PhD, congress president for ECR 2014 and head of the department of radiology at the Federal Center of Medicine and Rehabilitation in Moscow, during the live press conference.

This year also is being dubbed “the year of the brain,” with many presentations focusing on cutting-edge neuroimaging. The meeting serves as a major technological tradeshow featuring 300 exhibitors representing the gamut of medical imaging technology.

Follow select scientific sessions and industry news highlighted by Molecular Imaging on site in Vienna as ECR 2014 progresses.

 

 

 

Kathy Mahdoubi

Related Content

Researchers receive grant worth millions to develop portable PET scanner
Why is the US still dependent on foreign medical isotope production?
Downed high-flux reactor could restart sooner than anticipated
Some nuc med departments are already feeling the strain of the isotope shortage
NorthStar opens facility to assist with development and distribution of vital radioisotopes
Lizard saliva could be key to spotting elusive pancreatic tumors

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.